Prelude Therapeutics Inc (NASDAQ: PRLD) started the day on Wednesday, with a price increase of 10.55% at $2.83, before settling in for the price of $2.56 at the close. Taking a more long-term approach, PRLD posted a 52-week range of $0.61-$4.22.
It was noted that the giant of the Healthcare sector posted annual sales growth of -21.61% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -21.61%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 25.60%. This publicly-traded company’s shares outstanding now amounts to $43.75 million, simultaneously with a float of $27.77 million. The organization now has a market capitalization sitting at $160.23 million. At the time of writing, stock’s 50-day Moving Average stood at $1.86, while the 200-day Moving Average is $1.20.
Prelude Therapeutics Inc (PRLD) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Prelude Therapeutics Inc’s current insider ownership accounts for 50.95%, in contrast to 28.76% institutional ownership. According to the most recent insider trade that took place on Mar 25 ’25, this organization’s Chief Chemistry Officer bought 100,000 shares at the rate of 0.69, making the entire transaction reach 69,250 in total value, affecting insider ownership by 480,123. Preceding that transaction, on Mar 25 ’25, Company’s CEO bought 675,000 for 0.69, making the whole transaction’s value amount to 467,438. This particular insider is now the holder of 1,999,296 in total.
Prelude Therapeutics Inc (NASDAQ: PRLD) Trading Performance Indicators
Let’s observe the current performance indicators for Prelude Therapeutics Inc (PRLD). It’s Quick Ratio in the last reported quarter now stands at 3.21. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 15.26.
In the same vein, PRLD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.61, a figure that is expected to reach -0.03 in the next quarter, and analysts are predicting that it will be -0.42 at the market close of one year from today.
Technical Analysis of Prelude Therapeutics Inc (PRLD)
If we take a close look at the recent performances of Prelude Therapeutics Inc (NASDAQ: PRLD), its last 5-days Average volume was 0.44 million that shows plunge from its year to date volume of 0.5 million. During the previous 9 days, stock’s Stochastic %D was recorded 55.78% While, its Average True Range was 66.28.
Raw Stochastic average of Prelude Therapeutics Inc (PRLD) in the period of the previous 100 days is set at 59.09%, which indicates a major fall in contrast to 84.96% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.28 that was higher than 0.21 volatility it exhibited in the past 100-days period.
